Detalhe da pesquisa
1.
Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response.
PLoS Pathog
; 19(5): e1011359, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37256916
2.
A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence.
PLoS Pathog
; 18(5): e1010488, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35503780
3.
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses.
PLoS Pathog
; 12(8): e1005817, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27579713
4.
Immune activation is associated with CD8 T cell interleukin-21 production in HIV-1-infected individuals.
J Virol
; 88(17): 10259-63, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24942568
5.
Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity.
J Virol
; 88(9): 5165-70, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24554654
6.
Tailoring Tfh profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques.
Elife
; 122024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385642
7.
Tailoring Tfh Profiles Enhances Antibody Persistence to a Clade C HIV-1 Vaccine in Rhesus Macaques.
bioRxiv
; 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37503150
8.
Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques.
Front Immunol
; 14: 1139402, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37153584
9.
Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers.
J Virol
; 85(5): 2316-24, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21159862
10.
Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19.
JCI Insight
; 7(21)2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36136590
11.
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques.
Sci Immunol
; 7(73): eabl4102, 2022 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867800
12.
Vaccination induces HIV broadly neutralizing antibody precursors in humans.
Science
; 378(6623): eadd6502, 2022 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454825
13.
Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1.
Elife
; 102021 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34533134
14.
HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions.
JCI Insight
; 5(2)2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31996483
15.
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design.
Cell Host Microbe
; 25(1): 59-72.e8, 2019 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30629920
16.
Potent and broad HIV-neutralizing antibodies in memory B cells and plasma.
Sci Immunol
; 2(7)2017 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28783671
17.
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design.
Cell Host Microbe
; 26(2): 296, 2019 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31415756